CAS No. |
110590-61-9 |
|---|---|
中文名称 |
(S)-4-((S)-2-(((6S,9S,15S,18S)-1-氨基-15-((S)-仲丁基)-6-氨基甲酰-18-(4-羟基苄基)-9-(羟甲基)-1-亚氨基-8,11,14,17,20-五氧代-2,7,10,13,16,19-六氮杂二十一烷-21-基)氨基甲酰)吡咯烷-1-基)-3-((R)-2-氨基-3-巯基丙酰胺基)-4-氧代丁酸 |
英文名称 |
(S)-4-((S)-2-(((6S,9S,15S,18S)-1-amino-15-((S)-sec-butyl)-6-carbamoyl-18-(4-hydroxybenzyl)-9-(hydroxymethyl)-1-imino-8,11,14,17,20-pentaoxo-2,7,10,13,16,19-hexaazahenicosan-21-yl)carbamoyl)pyrrolidin-1-yl)-3-((R)-2-amino-3-mercaptopropanamido)-4-oxobutanoic acid |
别名 |
CDPGYIGSR-NH2;CYS-ASP-PRO-GLY-TYR-ILE-GLY-SER-ARG-NH2;H-CYS-ASP-PRO-GLY-TYR-ILE-GLY-SER-ARG-NH2;cys-asp-pro-gly-tyr-ile-gly-ser-arg*amide;cystinyl-aspartyl-prolyl-glycyl-tyrosyl-isoleucyl-glycyl-seryl-arginyl-NH2;Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2 (1);Laminin peptide 11;L-Cys-L-Asp-L-Pro-Gly-L-Tyr-L-Ile-Gly-L-Ser-L-Arg-NH2 |
标准英文名 |
(S)-4-((S)-2-(((6S,9S,15S,18S)-1-amino-15-((S)-sec-butyl)-6-carbamoyl-18-(4-hydroxybenzyl)-9-(hydroxymethyl)-1-imino-8,11,14,17,20-pentaoxo-2,7,10,13,16,19-hexaazahenicosan-21-yl)carbamoyl)pyrrolidin-1-yl)-3-((R)-2-amino-3-mercaptopropanamido)-4-oxobutanoic acid |
分子式 |
C40H63N13O13S |
分子量 |
965.44 |
精确分子量 |
965.44 |
SMILES |
SC[C@H](N)C(N[C@@H](CC(O)=O)C(N1[C@@H](CCC1)C(NCC(N[C@H](C(N[C@@H]([C@@H](C)CC)C(NCC(N[C@@H](CO)C(N[C@H](C(N)=O)CCCNC(N)=N)=O)=O)=O)=O)CC2=CC=C(C=C2)O)=O)=O)=O)=O |
标准SMILES |
C[C@@H](CC)[C@H](NC(=O)[C@H](CC1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O |
用途 |
Interferes with tumor cell adhesion to and invasion of the basement membrane; exhibits anti-angiogenic activity. |
InChIKey |
XJRPQJYLNDRHQD-JDIVNGTKSA-N |
|
|
评论 |
|---|